Roche Holding AG

01/27/2025 | Press release | Distributed by Public on 01/27/2025 00:00

Roche announces new results from EMBARK demonstrating significant sustained benefits of Elevidys in ambulatory individuals with Duchenne muscular dystrophy (DMD)

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.